The US Federal Government
The US Federal Government has mobilized to address the Opioid Epidemic and to provide pain management oversight.
-
The federal opioid-pain ecosystem and stakeholders
-
History of the federal response to the opioid/ pain challenge
-
Overview of current efforts and strategies
-
Monitoring the federal effort
-
Checklist for federal agencies and programs
-
Citizen tools box
-
Conversation
-
Content will be in various forms including check list, articles, infographs, interviews, links to other websites, video and other media forms.
Federal Government Opioid Pain Ecosystem and Stakeholders
Defense & Veterans Center for Integrative Pain Management provides a wide variety of tools, resources, meetings, and workshops available to the public. As a direct result of our research we have created several publicly available tools to assist in the treatment of acute and chronic pain management.
The Food and Drug Administration today 8/22/2018 awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures. FDA Commissioner Scott Gottlieb, M.D., said the “primary scope of this work is to understand what evidence is needed to ensure that all current and future clinical practice guidelines for opioid analgesic prescribing are sufficient, and what research is needed to generate that evidence in a practical and feasible manner.” FDA said this work would build on efforts started by the Centers for Disease Control and Prevention to develop federal guidelines on pain management and the use of opioids, but the guidelines FDA develops “would be based on prospectively gathered evidence drawn from evaluations of clinical practice and the treatment of pain.” In addition, Gottlieb said this work could potentially inform drug labelling. As part of the contract, NASEM will conduct a study and issue a report on its findings.
The 2010 Patient Protection and Affordable Care Act (ACA), Section 4305, required the Secretary of HHS to enter into an agreement with the IOM for activities “to increase the recognition of pain as a significant 7 public health problem in the United States.” As a result, HHS, working through the NIH, commissioned an IOM study to assess the state of pain care.
The resultant IOM report, issued in June 2011,1 included 16 recommendations for improvements in:
data collection and reporting
the availability and effectiveness of pain care public, patient, and professional education about pain, and
related preclinical, translational, and clinical research.